Impact of the Transition to International Financial Reporting Standards on M&A
05 November 2009
In the final M&A Briefing for the year, Foley attorneys Todd B. Pfister and Timothy H. Shea, with Brian Lightle of Deloitte & Touche LLP, discussed the potential adoption of IFRS by U.S. issuers and the impact of IFRS on M&A transactions. Specific topics included:
- What is driving the push to convert from U.S. GAAP to IFRS?
- What is the status of the SEC’s Roadmap to Conversion?
- What are some major differences between GAAP and IFRS?
- What implications do these differences have on cross-border transactions?
- How will the conversion to IFRS affect the valuation and due diligence processes?
- How should purchase agreement provisions be structured for the planned conversion to IFRS?
- How will the conversion to IFRS affect deal structure?
For more information about Foley’s M&A Briefing Series, please contact Jennifer Bartz at [email protected].
Related Insights
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”